Lippman Evan
Insider CIK 2062834 · TEVA EVP, Business Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-08-17 | 2026-08-19 | 18,600 | $36.57 | $680.2K | 25,591 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-08-17 | 2026-08-19 | 18,600 | $36.57 | $680.3K | 25,591 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-05-14 | 2026-05-18 | 74,008 | — | $0 | 74,008 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-05-14 | 2026-05-18 | 11,841 | — | $0 | 35,524 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-05-14 | 2026-05-18 | 35,912 | $35.58 | $1.28M | 44,191 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-05-14 | 2026-05-18 | 11,841 | — | $0 | 11,841 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-05-14 | 2026-05-18 | 5,746 | $35.58 | $204.4K | 6,095 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-05-14 | 2026-05-18 | 74,008 | — | $0 | 80,103 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2026-03-04 | 2026-03-06 | 27,347 | — | $0 | 27,347 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2025-05-14 | 2025-05-19 | 47,365 | — | $0 | 47,365 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2025-05-14 | 2025-05-19 | 148,016 | — | $0 | 148,016 | SEC↗ |